Aeterna Zentaris: Strong Cash Reserve Amidst Upcoming Merger
Company Announcements

Aeterna Zentaris: Strong Cash Reserve Amidst Upcoming Merger

Aeterna Zentaris Inc. (TSE:AEZS) has released an update.

Aeterna Zentaris Inc. announced a strong cash position of $29.5 million at the end of the first quarter of 2024, despite a net loss of $5.8 million due to increased expenses, partially offset by decreased R&D costs. The company also completed recruitment for its DETECT-trial and is on schedule to finalize a merger with Ceapro Inc. by the second quarter of 2024.

For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCOSCIENS Biopharma Debuts New Name and Ticker
GlobeNewswireAeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.
TheFlyAeterna Zentaris announces name change to Cosciens Biopharma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App